| 000 | 00000cam 2200000zi 4500 |
| 001 | 9.957671 |
| 003 | CaOODSP |
| 005 | 20260319150749 |
| 006 | m o d f |
| 007 | cr cn||||||||| |
| 008 | 251125e202601##onc ob f000 0 eng d |
| 020 | |a9780660799032 |q(statement) |
| 020 | |a9780660799049 |q(summary) |
| 040 | |aCaOODSP|beng|erda|cCaOODSP |
| 043 | |an-cn--- |
| 086 | 1 |aHP40-396/2025E-PDF |
| 086 | 1 |aHP40-396/2025-1E-PDF |
| 245 | 00|aUpdated guidance for use of rabies vaccine for pre-exposure prophylaxis (PrEP). |
| 264 | 1|aOttawa, ON : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cJanuary 2026. |
| 264 | 4|c©2026 |
| 300 | |a1 online resource (51 pages) + |esummary (5 pages) |
| 336 | |atext|btxt|2rdacontent |
| 337 | |acomputer|bc|2rdamedia |
| 338 | |aonline resource|bcr|2rdacarrier |
| 500 | |aIssued also in French under title: Directives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE). |
| 500 | |a"An advisory committee statement (ACS), National Advisory Committee on Immunization (NACI)"--Cover. |
| 500 | |a"Pub.: 250365"--Page 2 (summary). |
| 500 | |aThe publication file in PDF format has been replaced on 19 March 2026 as requested by the Public Health Agency of Canada. |
| 504 | |aIncludes bibliographical references (pages 45-51). |
| 650 | 0|aRabies|xVaccination|xGovernment policy|zCanada. |
| 650 | 0|aRabies vaccines|xGovernment policy|zCanada. |
| 710 | 2 |aPublic Health Agency of Canada, |eissuing body. |
| 710 | 1 |aCanada. |bNational Advisory Committee on Immunization, |eissuing body. |
| 775 | 08|tDirectives mises à jour sur l'utilisation des vaccins contre la rage pour la prophylaxie préexposition (PPrE).|w(CaOODSP)9.957672 |
| 856 | 40|qPDF|s669 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-eng.pdf|zStatement |
| 856 | 40|qPDF|s212 KB|uhttps://publications.gc.ca/collections/collection_2026/aspc-phac/HP40-396-2025-1-eng.pdf|zSummary |
| 986 | |a250365 |